APRICITABINE AND NRTI COMBINATION THERAPY

摘要

The present invention provides a method of treating HIV-1 infection in a subject win which the HIV1 is drug resistant. The method comprises administering to the subject a combination of anti-HIV-1 agents wherein the combination comprises an effective dose of Apricitabine and an effective dose of Abacavir.